Category: Lung Cancer

Home / Clinical Research / Lung Cancer
Treatment of malignancy associated weight loss or anorexia in patients with NSCLC
Post

Treatment of malignancy associated weight loss or anorexia in patients with NSCLC

STUDY TITLE: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in adult patients with Advanced Non-Small Cell Lung Cancer (NSCLC) INDICATION: Treatment of malignancy associated weight loss or anorexia in patients with NSCLC. STUDY DRUG: Anamorelin...

QUILT 3.055 Study – Multiple Solid Tumor Cancers
Post

QUILT 3.055 Study – Multiple Solid Tumor Cancers

QUILT-3.055: A Phase 2b, Single-Arm, Multicohort, Open-Label Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment with PD-1/PD-L1 Immune Checkpoint Inhibitors.     DRUGS: N-803 (aka ALT-803) + PD-L1 t-haNK suspension for infusion This study is designed to treat multiple solid tumor cancers. This type of study is done because of how the...

Lung Cancer Genomic Testing (EGFR, KRAS, ALK)
Post

Lung Cancer Genomic Testing (EGFR, KRAS, ALK)

Medical oncologist Marc Kris has been a key player in helping bring personalized medicine to people with lung cancer. He leads a research team working to find new genetic targets in cancer cells and to test anticancer medicines that specifically attack the lung cancers driven by these molecular changes.

BASKET Study – Covers multiple solid tumor cancer types
Post

BASKET Study – Covers multiple solid tumor cancer types

An Open-label, Multicenter, Multicohort, Phase 2 Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202) This study is designed to treat multiple solid tumor cancers. This type of study is done because of how the drug is expected to work against cancer. This study will enroll...

QUILT 2.023 Study – Lung Cancer
Post

QUILT 2.023 Study – Lung Cancer

QUILT-2.023: A PHASE 3, OPEN-LABEL, 3-COHORT RANDOMIZED STUDY OF N-803 IN COMBINATION WITH CURRENT STANDARD OF CARE VS STANDARD OF CARE AS FIRST-LINE TREATMENT FOR PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) Lung cancer begins in the lungs and most often occurs in people who smoke. While this is a very simple...

Zeno Study – Lung Cancer
Post

Zeno Study – Lung Cancer

A Phase I/2 Open Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of ZN-e4 (KP-673) in Patients with Advanced Non-Small Cell Lung Cancer with activating Epidermal Growth Factor Receptor (EGFR) mutations The cells in our bodies are constantly dividing to create new cells and new tissue. This division requires the cell...